PATENT CLAIM ANALYSIS

Application Number: 16094243
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["544", "297000"]

Abstract:
The present invention relates to new polymorphic forms of Crystalline Rosuvastatin calcium along with novel processes for crystalline as well as amorphous Rosuvastatin calcium.

Claim (Index 6):
A process of  claim 4 , in which anti-isomer content is very low (<0.1% by HPLC) or even \u2018Not Detected\u2019.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 97.0
- Lexical Diversity: 1.13636
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13885509', '12449426', '13574005', '14901721', '13143943']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.832244789387551
- 35 USC 102 Novelty (BERT): 0.5327765911773821
- Combined Prediction Score: 0.8022979695665341
- Mean Citation Score: 386.299474
- Max Citation Score: 421.883
- Similarity Product: 168.6102338721156

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test